Implicator
The timing was not subtle. OpenAI announced ChatGPT for Health on a Monday. Five days later, Anthropic fired back with Claude for Healthcare. The setting for both: JP Morgan's annual healthcare conference in San Francisco, where hospital executives hunt for capital and AI companies hunt for customers. HIPAA-ready infrastructure. Clinicians, insurers, patients. The pitch from both companies could have been written by the same marketing team.
And both entered a market littered with the remains of previous attempts by horizontal technology companies to fix American healthcare.
Anthropic is currently negotiating a $10 billion funding round that would value the company at $350 billion. The healthcare push is not charity work. It is a bet that Claude can succeed where Microsoft HealthVault and Google Health failed, where countless electronic health record integrations have stalled, where the promise of consolidated patient data has been made and broken for two decades.
Harkaram Grewal
Maps the India–Germany–U.S. AI triangle from New Delhi. Background in cross-market operations and business development. Writes about supply chains, enterprise adoption, and talent—the unsexy forces that actually move global AI.
